Related Experiment Video
Updated: Oct 14, 2025

09:06
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
12.3K
Multimodal Imaging and Visual Evoked Potentials Reveal Key Structural and Functional Features That Distinguish
Sai Manohar Thota1, Kimberly L Chan2, Sai Sanwid Pradhan1
1Department of Biosciences, Sri Sathya Sai Institute of Higher Learning, Puttaparthi, Andhra Pradesh, India.
Neurology India
|November 8, 2021
Summary
Huntington's disease (HD) shows distinct brain differences in Indian patients. Symptomatic HD reveals significant volumetric loss and altered neurochemistry compared to presymptomatic stages, aiding progression monitoring.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Indian Population Studies
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Lack of matched structural and functional brain analyses in Indian HD cohorts.
- Need for sensitive, noninvasive imaging biomarkers for HD.
Purpose of the Study:
- To investigate structural and functional brain differences in Indian HD patients versus controls.
- To compare presymptomatic HD (P-HD) and symptomatic HD (S-HD) brain characteristics.
Main Methods:
- Examined 17 HD patients (6 P-HD, 11 S-HD) and 12 controls from India.
- Utilized macrostructural, microstructural, and functional brain imaging.
- Assessed neurochemical levels, glucose metabolism, and visual latencies.
Main Results:
- HD brains exhibited increased intercaudate distance, subcortical volume loss, and altered diffusivity.
- Lower N-acetyl aspartate and higher choline levels were observed in HD brains.
- S-HD showed greater volumetric loss and diffusivity in caudate/putamen compared to P-HD.
Conclusions:
- Distinct macrostructural, microstructural, and functional brain differences exist in Indian HD patients.
- Symptomatic HD patients display significant volumetric loss, increased diffusivity, and altered neurochemistry versus P-HD.
- Clinical monitoring of these brain alterations may help track HD progression.

